Blood Pressure Variability: Assessment, Predictive Value, and Potential as a Therapeutic Target

作者: Gianfranco Parati , Juan Eugenio Ochoa , Carolina Lombardi , Grzegorz Bilo

DOI: 10.1007/S11906-015-0537-1

关键词:

摘要: A large body of evidence has consistently supported the relationship between blood pressure (BP) levels and risk cardiovascular complications. In recent years, several independent studies have also indicated that this may not only depend on magnitude elevation per se but presence other associated conditions such as increased variability. This concept been by a series reports, most which post hoc analyses clinical trials in hypertension, showing increasing values BP variability (BPV) (either short term, midterm, or long term) predict development, progression, severity cardiac, vascular, renal organ damage, well events mortality. Remarkably, conducted populations at high shown BPV individual subjects (so-called intra- within-individual BPV) to be strong predictors morbidity mortality, even larger extent than average values. However, low moderate risk, contribution prediction over beyond moderate. The aim paper is critically review addressing prognostic relevance different components yet open question, i.e., whether routine assessment practice should regarded an additional target antihypertensive treatment improve protection.

参考文章(168)
World Health Organization, International Society of Hypertension Writing Group, None, 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. Journal of Hypertension. ,vol. 21, pp. 1983- 1992 ,(2003) , 10.1097/00004872-200311000-00002
Katarzyna Stolarz-Skrzypek, Lutgarde Thijs, Yan Li, Tine W Hansen, José Boggia, Tatiana Kuznetsova, Masahiro Kikuya, Gladys Maestre, Luis Mena, Kalina Kawecka-Jaszcz, Jan A Staessen, None, Short-term blood pressure variability in relation to outcome in the International Database of Ambulatory blood pressure in relation to Cardiovascular Outcome (IDACO). Acta Cardiologica. ,vol. 66, pp. 701- 706 ,(2011) , 10.1080/AC.66.6.2136952
P A Meredith, H L Elliott, FDA guidelines on trough: peak ratios in the evaluation of antihypertensive agents. United States Food and Drug Administration Journal of Cardiovascular Pharmacology. ,vol. 23, ,(1994)
Roberto Sega, Giancarlo Cesana, Michele Bombelli, Guido Grassi, Maria Luisa Stella, Alberto Zanchetti, Giuseppe Mancia, Seasonal variations in home and ambulatory blood pressure in the PAMELA population Journal of Hypertension. ,vol. 16, pp. 1585- 1592 ,(1998) , 10.1097/00004872-199816110-00004
Paul Muntner, Emily B. Levitan, Cara Joyce, Elizabeth Holt, Devin Mann, Suzanne Oparil, Marie Krousel-Wood, Association Between Antihypertensive Medication Adherence and Visit‐to‐Visit Variability of Blood Pressure Journal of Clinical Hypertension. ,vol. 15, pp. 112- 117 ,(2013) , 10.1111/JCH.12037
William G. Haynes, Role of leptin in obesity-related hypertension. Experimental Physiology. ,vol. 90, pp. 683- 688 ,(2005) , 10.1113/EXPPHYSIOL.2005.031237
Yi-Ting Hsieh, Shih-Te Tu, Tzu-Jung Cho, Shun-Jen Chang, Jung-Fu Chen, Ming-Chia Hsieh, Visit-to-visit variability in blood pressure strongly predicts all-cause mortality in patients with type 2 diabetes: a 5·5-year prospective analysis. European Journal of Clinical Investigation. ,vol. 42, pp. 245- 253 ,(2012) , 10.1111/J.1365-2362.2011.02574.X
Giuseppe Mancia, Stefano Omboni, Antonella Ravogli, Gianfranco Parati, Alberto Zanchetti, Ambulatory blood pressure monitoring in the evaluation of antihypertensive treatment: additional information from a large data base Blood Pressure. ,vol. 4, pp. 148- 156 ,(1995) , 10.3109/08037059509077587